Akèy › Dyabèt Tip 2
Etid klinik pou Dyabèt Tip 2 ap rekrite nan Etazini
240 etid pou Dyabèt Tip 2 ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- San Antonio, TX37 etid
- Houston, TX31 etid
- Orlando, FL24 etid
- Boston, MA20 etid
- Chicago, IL19 etid
- Dallas, TX19 etid
- Miami, FL19 etid
- Columbus, OH18 etid
- Las Vegas, NV18 etid
- Atlanta, GA17 etid
- San Diego, CA17 etid
- Los Angeles, CA16 etid
- New York City, NY16 etid
- Birmingham, AL16 etid
- Arlington, VA15 etid
- Jacksonville, FL15 etid
- Philadelphia, PA15 etid
- Havelock, NC13 etid
- Indianapolis, IN12 etid
- Austin, TX12 etid
- Cincinnati, OH12 etid
- Washington, DC12 etid
- Aurora, CO11 etid
- Omaha, NE11 etid
- Long Beach, CA11 etid
- Salt Lake City, UT11 etid
- Durham, NC11 etid
- Albuquerque, NM11 etid
- Kansas City, MO11 etid
- New Haven, CT10 etid
- Ann Arbor, MI10 etid
- Tucson, AZ10 etid
- Hialeah, FL10 etid
- Oklahoma City, OK10 etid
- Pittsburgh, PA10 etid
- Baltimore, MD10 etid
- Wichita, KS10 etid
- Deltona, FL10 etid
- Concord, CA10 etid
- Little Rock, AR10 etid
Pa eta
- Alabama22 etid
- Arizona22 etid
- Arkansas11 etid
- Ayiti7 etid
- Colorado16 etid
- Connecticut14 etid
- Distrik Columbia7 etid
- Florid48 etid
- Georgia34 etid
- Idaho12 etid
- Illinois30 etid
- Indiana18 etid
- Iowa10 etid
- Kalifòni67 etid
- Kansas15 etid
- Kentucky12 etid
- Lwizyàn15 etid
- Maryland26 etid
- Massachusetts29 etid
- Michigan27 etid
- Minnesota17 etid
- Mississippi9 etid
- Missouri20 etid
- Montana4 etid
- Nebraska14 etid
- Nevada18 etid
- New Jersey15 etid
- New Mexico12 etid
- New York33 etid
- North Carolina36 etid
- North Dakota6 etid
- Ohio41 etid
- Oklahoma13 etid
- Oregon7 etid
- Pennsylvania30 etid
- Rhode Island3 etid
- South Carolina20 etid
- South Dakota3 etid
- Tennessee18 etid
- Texas58 etid
- Utah19 etid
- Virginia26 etid
- Washington20 etid
- West Virginia7 etid
- Wisconsin9 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07064473A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07783802A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07564414A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07754461Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07817251NT-ProBNP-based Heart Failure Screening and Prevention Trial in Patients With Type 2 Diabetes: STRONG-DM Study
Ap rekrite
Tout laj · Tout sèks · Mizajou Sep 29, 2026 · NCT06593327A Study of PATAS Using Single Ascending Doses in Healthy Volunteers and Multiple Ascending Doses in Diabetic Subjects
Ap rekriteFaz 1
Laj 18 a 65 · Tout sèks · Mizajou Sep 29, 2026 · NCT07223333A Randomized Controlled Trial of Diabetes Screening Immediately Postpartum (DIP) and Follow Up PP CARE
Ap rekrite
Laj 18 ak plis · Fanm · Mizajou Sep 29, 2026 · NCT05909046A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
Ap rekriteVolontè an sante akeyi
Laj 55 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT06112418Using Continuous Glucose Monitoring to Quantify the Effects of NOURISH's Culturally Modified Meals on Asian Americans With Type 2 Diabetes
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT06836479A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07595549Study of ALV-100 to Assess Safety, Tolerability, and PK/PD in Overweight/Obese Participants With or Without T2D
Ap rekriteFaz 1
Laj 18 a 65 · Tout sèks · Mizajou Sep 28, 2026 · NCT07399678A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07776509ACCESS 2: AI for pediatriC diabetiC Eye examS Study 2
Ap rekrite
Laj 8 a 21 · Tout sèks · Mizajou Sep 23, 2026 · NCT05463289Pre-diabetes in Subject With Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT)
Ap rekriteVolontè an sante akeyi
Laj 18 a 65 · Tout sèks · Mizajou Sep 22, 2026 · NCT02969798A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07282600A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07784270Phenotyping Genetic Risk for Type 2 Diabetes
Ap rekriteVolontè an sante akeyi
Laj 10 a 70 · Tout sèks · Mizajou Sep 21, 2026 · NCT04024631Improving the Collaborative Health of Adult Dyads
Ap rekriteVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT05370014Sleep Loss and Circadian Misalignment - Mechanisms of Insulin Resistance
Ap rekriteFaz 4Volontè an sante akeyi
Laj 18 a 45 · Tout sèks · Mizajou Sep 18, 2026 · NCT07494084Youth-Onset Type 2 Diabetes and Heart Disease: The Young at Heart Prospective Cohort Study
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 12 a 25 · Tout sèks · Mizajou Sep 17, 2026 · NCT06730113Plant-Based Online Weight Loss Through Education and Resources Program and Study
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 17, 2026 · NCT07095543A Study to Evaluate ALN-4324 on Insulin Sensitivity in Adults With Type 2 Diabetes Mellitus
Ap rekriteFaz 2
Laj 18 a 65 · Tout sèks · Mizajou Sep 16, 2026 · NCT07465224Cooking Health-Oriented Meals to Prevent Dementia and Diabetes
Ap rekriteVolontè an sante akeyi
Laj 50 a 75 · Tout sèks · Mizajou Sep 16, 2026 · NCT07661368A Study to Investigate the Relative Bioavailability and Safety of Different Oral Formulations of Elecoglipron in Healthy Participants
Ap rekriteFaz 1Volontè an sante akeyi
Laj 18 a 55 · Tout sèks · Mizajou Sep 16, 2026 · NCT07723833Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.